高强度间歇联合抗阻训练改善系统性硬化症患者疼痛与疲劳:欧洲多中心随机对照试验
这项欧洲多中心随机对照试验纳入170例系统性硬化症患者,随机分为运动干预组(每周两次、共12周监督下HIIT联合抗阻训练)与常规护理组。12周时,干预组在疲劳、疼痛、抑郁、生活质量、功能、肌骨力量与耐力及心肺适能方面较常规护理组显著改善,且HIIT联合抗阻训练在研究人群中安全。
要点
- 12周监督下HIIT联合抗阻训练可显著改善系统性硬化症患者的疲劳与疼痛。
- 干预组在抑郁、生活质量、功能、肌骨力量/耐力及心肺适能方面也显著改善。
- HIIT联合抗阻训练在研究人群中安全,可能作为药物治疗的有效非药物辅助。
核心结论
- 12周监督下联合上肢运动方案可改善系统性硬化症患者的疼痛、疲劳、抑郁、生活质量、功能、力量及心肺适能。
- HIIT联合抗阻训练在研究人群中安全,可能作为药物治疗的有效非药物辅助以管理SSc症状并提升生活质量。
研究设计与样本
- 欧洲多中心随机对照试验(n=6),纳入170例系统性硬化症患者(89%为局限皮肤型SSc),随机分为运动干预组或常规护理组。
- 运动干预组在常规护理基础上完成12周、每周两次的监督下方案,包括30分钟高强度间歇训练(HIIT)和15分钟抗阻训练(RT);常规护理组仅接受常规护理。
- 结局在基线、12周(主要终点)和24周评估,主要结局为疼痛和疲劳,次要结局包括生活质量、抑郁、功能能力、肌骨力量/耐力及心肺适能。
主要发现
- 12周时,与常规护理组相比,运动干预组疲劳的平均组间差异为-10.4(95%CI 19.4至-1.4),p<0.05。
- 12周时,与常规护理组相比,运动干预组疼痛的平均组间差异为0.48(95%CI 0.21至0.76),p<0.05。
- 12周时,运动干预组较常规护理组在抑郁(p<0.001)、生活质量与自报功能(p<0.05)、探索性结局肌骨力量与耐力(p<0.01)及心肺适能(p<0.001)方面显著改善。
临床怎么用
- 对于系统性硬化症患者,12周监督下HIIT联合抗阻训练可能作为药物治疗的非药物辅助,以管理症状并提升生活质量。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pain and fatigue are among the most debilitating symptoms of systemic sclerosis (SSc), severely impairing quality of life (QoL). Pharmacological management is often inadequate, and evidence on exercise is limited. This study aimed to evaluate the effects of a tailored exercise programme on pain and fatigue in people with SSc (PwSSc). METHODS: This European multicentre randomised controlled trial (n=6) recruited 170 PwSSc (89% limited cutaneous SSc), randomised to an exercise intervention group (EIG) or usual care group (UCG). The EIG completed a 12-week, twice-weekly supervised programme combining 30 min of high-intensity interval training (HIIT) and 15 min of resistance training (RT), in addition to usual care. The UCG received usual care alone. Outcomes were assessed at baseline, 12 weeks (primary endpoint) and 24 weeks, with pain and fatigue as primary outcomes, and QoL, depression, functional ability, musculoskeletal strength/endurance and cardiorespiratory fitness as secondary outcomes. RESULTS: At 12 weeks, the mean group differences for the primary, fatigue (-10.4 (95% CI 19.4 to -1.4), p<0.05) and pain (0.48 (95% CI 0.21 to 0.76), p<0.05), secondary, depression (p<0.001), QoL and self-reported function (p<0.05) and exploratory outcomes musculoskeletal strength and endurance (p<0.01), and cardiorespiratory fitness (p<0.001) were significantly improved in EIG compared with UCG. CONCLUSIONS: A 12-week supervised combined upper body exercise programme can improve pain, fatigue, depression, QoL, function, strength and cardiorespiratory fitness in PwSSc. HIIT combined with RT is safe for the study population and may serve as an effective non-pharmacological adjunct to pharmacotherapy to manage SSc symptoms and enhance QoL. TRIAL REGISTRATION NUMBER: NCT05234671.
引用
- Mitropoulos A, Jensen KY, Kouidi E, et al. High-intensity interval and resistance training programme improves pain and fatigue outcomes in people with systemic sclerosis: a European multicentre randomised controlled trial. RMD Open. 2025. PMID: 41219127. doi:10.1136/rmdopen-2025-005946
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。